Susan Desmond-Hellmann, MD, MPH The pharmaceutical industry gets a bad rap for having a corrupting influence on clinical trials, but that perception undermines the many scientific breakthroughs that have come from industry-backed research, according to UC San Francisco’s chancellor.
April 29, 2013
December 13, 2011
UCSF Chancellor Susan Desmond-Hellmann, MD, former president for product development at Genentech, is featured in a video interview for BioCentury Publications Inc., a major biopharmaceutical news media source, which first aired online on Dec. 11.
June 30, 2011
Erik Lium has been named assistant vice chancellor of UCSF's newly created Office of Innovation, Technology and Alliances to provide the strategic leadership to both support innovation on campus and foster external alliances to advance biomedical research.
May 05, 2011
Yervoy, a new cancer drug that has been approved for the treatment of late-stage melanoma – and that is being used to treat other cancers in ongoing clinical trials – is based on a strategy for boosting the immune response developed and tested by scientists from UCSF and UC Berkeley.
February 28, 2011
UCSF and Zcube have entered into a new agreement to license UCSF-developed microtechnology and support early research into new ways to deliver oral medications directly to a targeted site in the body.
February 24, 2011
The California Institute for Quantitative Biosciences (QB3) at Mission Bay celebrates a decade of driving the bioeconomy and spells out its goal of helping the state foster science and innovation to benefit society.
February 03, 2011
UCSF Nobel laureate Elizabeth Blackburn is not ready to predict how long you will live. But she and her UCSF colleagues are exploring a feature within cells that is a kind of hourglass for aging.
December 13, 2010
Current and future scientists of all backgrounds will convene at UCSF Mission Bay on December 17 through a biotech networking event that draws students from City College of San Francisco.
November 29, 2010
A UCSF research collaboration with GE Healthcare has produced the first results in humans of a new technology that promises to rapidly assess the presence and aggressiveness of prostate tumors in real time, by imaging the tumor’s metabolism.
November 16, 2010
Amy Pyle, a veteran journalist with more than 20 years experience in communications, has joined UCSF as executive director of news and media relations.